amphotericin-b has been researched along with Glomerulonephritis--Membranous* in 1 studies
1 other study(ies) available for amphotericin-b and Glomerulonephritis--Membranous
| Article | Year |
|---|---|
Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy.
Mucormycosis is a rare and fatal opportunistic infection occurring in severely immunocompromised patients. Here, we report, for the first time, on a 65-year-old man with idiopathic membranous nephropathy and moderate renal dysfunction who suffered from life-threatening pulmonary mucormycosis during immunosuppressive therapy. After amphotericin B (AmB) administration with a total accumulating dose of 1.5 g, not only has he recovered from this fatal infection, but also his nephrotic syndrome has entered complete and long-term remission without any continued corticosteroid and immunosuppressive therapy during the 6-year follow-up. Serum creatinine levels remained stable by adjusting the tolerable daily dose of AmB during the period of treatment. Topics: Aged; Amphotericin B; Antifungal Agents; Glomerulonephritis, Membranous; Humans; Immunosuppression Therapy; Male; Mucormycosis; Nephrotic Syndrome; Remission, Spontaneous | 2014 |